KFU research group finds ways to disrupt protein synthesis in Staphylococcus aureus

NewsGuard 100/100 Score

It is well known that many strains of Staphylococcus are resistant to antibiotics, and research groups around the world seek new targets in the bacteria to decrease their infectious potential.

The most popular target for antibiotics is the protein synthesis apparatus of a cell, in particular, ribosomes. One of the promising directions for experiments is regulating the synthesis of proteins in pathogens by affecting specific proteins which regulate ribosome functioning."

Konstantin Usachev, Head of KFU research group, Leading Research Associate

The work is supported by Russian Science Foundation's grant program for young research teams.

"The elongation cycle (extension of the protein chain by one amino acid residue) is the most conservative stage of protein synthesis in all living organisms. At the same time, there are areas of proteins that are "difficult" for the synthesis of the ribosome, such as proline-proline (proline is one of the twenty amino acids that make up proteins). In this case, proline-proline sites are very often found in the composition of the proteins of secretory systems, which, in turn, are necessary for the isolation of pathogenicity factors. In order to help the ribosome to synthesize such sites, there is a special protein - the elongation factor P (EF-P). However, some organisms have a special post-translational modification in the structure of the EF-P protein - an additional group of atoms that helps stabilize tRNA inside the ribosome. Whether such a modification was present in Staphylococcus aureus was not known. We managed to detect it and show what type of modification is present in EF-P from Staphylococcus aureus, which, in turn, can be used as a target for disrupting the functioning of this protein in the pathogen. We think creating drugs that disrupt the EF-P modification process will help disable the pathogenic properties of Staphylococcus aureus," elaborates Usachev on the content on this particular paper.

Source:
Journal reference:

Golubev, A., et al. (2020) Posttranslational modification of Elongation Factor P from Staphylococcus aureus. FEBS Open Bio. doi.org/10.1002/2211-5463.12901.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover mechanism behind mitochondrial dysfunction in Alzheimer's